Evolv Sets Senior Employee Severance Plan

By Donald Maye, Published Nov 04, 2022, 10:11am EDT (Info+)

While Evolv's stock is down 70% since SPACing last year and has been subject to immense scrutiny, including this week's BBC investigation, Evolv's board has just approved a generous, albeit unfunded, severance plan for "senior level employees" at the company.

IPVM Image

Inside this note, we examine the structure of this plan, how this benefits senior employees at the beleaguered company and what risks Evolv faces as it enters 2023.

Plan *********

***** ***** ********** *** ****** ** ******* ******** *** *** **** ****** * scenarios.

Commonplace *********** ******

** * "****** ***** ********" ** terminated ******* ***** (*.*., * *********** firing), **** ***** ******** **** ******* a ******* ** * ******' **** salary *** ***-***** ***** (** ** 12 ******).

Change ** ******* ******

** ***** ** * "****** ** control" (*.*., ***** ** ********), *** payout ** ************* ******. *** **** salary **** ** **% ******* **** just * *********** *********** (*.*., * minimum ** * ****** ** ** 18 ******), ***** ****** ***, **** importantly, "**** ************ ** *** ***********, unvested ***** *******, ********** ***** ***** or ***** ***** ******".

*** *******, *****'* *** ***** ** approximately **** * ******* ******* ** a *********** *********** *** **** $* million ** ***** *** ********, ** we ******** ** *** ***** *****:

IPVM Image

Tiers *******

*** ** ***** ** ******* ** a "****** ***** ********" ** ******* but ** ** ** ***** *** CEO, *** ***, *** "********* ********" at *** *******. *******, ** *** also ****** ** ****** ** *** company's **********. *** *******, *** **** mentions ********* ******** ** **** * or *, ** *** ******* ***** shows:

*** *******’* ***** ********* *******, ***** George, *** ***** ********* *******, **** Donohue, **** *********** ** *** ********* Plan ** **** ************* *** *** Company’s ***** ********* ******** **** *********** in *** ********* **** ** ****** Tier * ** **** * ************ depending ** ***** *********.

*******, *** **** ********** ******** * "Tier *". ** ***** *** **** any ********* ** *** ******** **** defines *** ** ******** ** **** or *** *** ***** ** ** being * ***** ****, ** ** reasonable ** ******* **** ****** **** senior *********. ***** ***** ***** ***** the **** ****** ****** ******* ****** tiers:

IPVM Image

**** ******** ****** *******, ********, ********'* ********** ****, *** ********* * ******* ** 15 ***** ********** *******. ***** ** a ********* ** ***** **** ********** listed ** ********:

IPVM Image

********

*** **** ** "********" ** ** or **** *** **** ***** **** occurs, ***** **** **** ** *** the ******** ** **** ** ******** to ***** ***** ********:

*** **** ***** ** ********, *** all **** ******** ***** *** **** paid **** **** *** ******* ****** of *** *******

Good *** *********, *** *** *********

***** ***** ********* ** **** ****'* SPAC **** **** ************* ******* *****, Evolv's ****** ***** ********* *** *** well ********** *** ******* *****, **** if *****'* *********** **** *** *******.

Comments (6)

****** **** **** *** ************ ** acquisition. ***** *** ** ********* ** see **** *** ****** **** ********.

Agree: 5
Disagree
Informative: 1
Unhelpful
Funny

*** *******, *** ******, ******** ** an ******** *** *** * **** on *** ***** *****, ** ******** would ** **** ******** / ********** to ******* *****.

*** ********, ****** ** *** **** would ******** **** ** ***?

*****'* ****** *** ***** ** ~$*** million, ***** **** ** **** ** of **** **** *** ~$*** ******* (and **** ****** ~$** ******* ** H1 ****).

**** ***** *****'* ********** ***** ~$*** million. ***** *****'* ******** *** *********** from ****, * ***'* ***** ****'* a **** ***** ** *** (*** of ****** ******** ***** **** ** pay * ******* *******). *** ******** may ***** *********** ** *** ***** may ******* *******, ******** ****** ** more **********.

Agree
Disagree
Informative: 2
Unhelpful
Funny

**,

**** *** **** * ********** **** since ** ***** **** *** * board ****. ********** ** *** ****** they ***, ******** ***** ** ** the ******* ********* ***** ****.

Agree: 1
Disagree
Informative
Unhelpful
Funny

**** ******* ** **** *** *** of ***** ****** ****** ******** ****?

**** ****** ********'* ********** ******** *** suffered *** ** *** ***** ***** tanking, **** ****** *** **** ******** actually ** *** ******** ******** ** the ***** ******* ****** ***** *** ponied ** $$ ** *** **** and **** ***** ***** ** ** the ****.

*** ***** ******** *** ******** ** acquire **** ******* ** **** ******* for **** ** ****** ********* ** vacuum ** *** ******* ** * bankruptcy **** ****?

*** ** **** ***** **** **** want *** *** ******* ** *** dollar **** **** *** **** **** before **** **** ** ** *** next *** *****.

Agree
Disagree
Informative
Unhelpful
Funny

***** *** **** ** **** ** $242 ******* ** *** *** ** June **** ************ ~$** ******* ** ** ****. Assume ****'* * ******** **** ****, they *** *** ** **** ** end ** ****.

*******, *** **** **** ** ****** to ******* ****** *** ** ************* increased ***** / ****** *********** (*.*., losing **** *****) ** ** ******* costs (*.*., ** **** ******* **** are *** ******* ***** ******).

***/***, ******* *** ** ***** ** not * ******* ******* *** *****.

*** ***** ******** *** ******** ** acquire **** ******* ** **** ******* for **** ** ****** ********* ** vacuum ** *** ******* ** * bankruptcy **** ****?

*** *******, ******** $*** ******* *** ************** *** *** $** ******* ** revenue ******* ******** ********** *** *********** cost *** ******* *** *** **** that **** ***** **** ** *** even **** ** *** ****** (***** as ** **** **** ***** *** be ****).

*** ********'* ********** ** **** ****** / ****** **** *****'* ****** **** is ********* * ******** ** ********* applications (****** ****** ****** ******* "****" is * *** ****** **** ****** concealed ****** *********).

Agree
Disagree
Informative
Unhelpful
Funny

*** *******, **** **** $*** ******* for ******** ****** *** *** $** million ** *******

******** ** * ****-**** ****** ** the ******** ******.

*** ** ***** ****'*.

***** **** ********** ** *** ******** market ***** **** ** ********* ** take ** *** ******** **-****** ********, I ***'* ***** ******** ** *******.

****** ** ******** *** *** ** be * ******, ****** ****** ******** by ****** ** ****.

Agree
Disagree
Informative
Unhelpful
Funny
Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports